For the third straight year, Louis P. Kassa III, MPA, chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC), has been chosen by the Philadelphia Business Journal for its
Lifesaving research by scientists, doctors and others around our country is being threatened by what’s happening currently in Washington, D.C., say officials of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center (PABC).“Medical research
The Baruch S. Blumberg Institute, presented the 2024 Lam Excellence in Medicinal Chemistry Award recently to Marianne Carlsen, senior scientist at Fox Chase Therapeutics Discovery, Inc. (FCTDI), located in Doylestown.(L-R) Dr. Ju-Tao Guo; Blumberg Institute; Dr. Allen
[caption id="attachment_19220" align="alignright" width="215"] Governor Kathy Hochul[/caption] New York State officials today announced the team that has been selected to build and launch BioGenesis, a cell and gene therapy center on Long Island, which will include a biotech
Dr. Timothy Block will share his thoughts about launching the Foundation, Blumberg Institute and Pennsylvania Biotechnology Center (PABC). Doylestown, Pa., Aug. 26, 2024 – When Timothy M. Block, PhD, an award-winning virologist and accomplished inventor, launched the
Joel D. Rosen, Esq, managing partner of High Swartz LLP, has been elected Chair of the Baruch S. Blumberg Institute’s Board of Directors.Located in Doylestown, the Blumberg Institute is a nonprofit organization established by the Hepatitis B
Dr. Kunwar Shailubhai Biotech entrepreneur and Blumberg Institute professor Kunwar Shailubhai, PhD, the pioneer of therapeutic applications of guanylate cyclase-C (GC-C) signaling and an inventor of the widely prescribed medicine Trulance(R), has been awarded a Phase 1
Through a pilot program aimed at accelerating and supporting life sciences startups in our state, the Pennsylvania Biotechnology Center (PABC)will provide financial support and free lab space to more than a dozen startups at the PABC in Doylestown, its B+labsincubator in Philadelphia and elsewhere in Pennsylvania. The PABC’s new initiative, the Academic Innovation Zone, is managing $5 million through the Commonwealth of
(L-R) Zhengyuan Jiang of the Blumberg Institute, Dr. Patrick Y. S. Lam and Steven Kultgen of Arbutus Biopharma. The Baruch S. Blumberg Institute presented the 2023 Lam Excellence in Medicinal Chemistry Award recently to Steven Kultgen of Arbutus Biopharma,
The collaboration will support the advancement of life sciences companies in Greater Philadelphia Hatch BioFund Management LLC (“Hatch BioFund”), an early- stage life sciences venture capital firm headquartered in the Philadelphia region, and Brandywine Realty Trust (“Brandywine”), one
